No Data
This Market Is The Buying Opportunity Of A Lifetime
Thermo Fisher Scientific | 10-Q: Quarterly report
RoosterBio Announces Collaboration With Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing
Argus Research Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating
Those Who Invested in Thermo Fisher Scientific (NYSE:TMO) Five Years Ago Are up 31%
Argus Adjusts Price Target on Thermo Fisher Scientific to $470 From $620
loading...